Conclusion
Guillain-Barre Syndrome (GBS) is oftentimes a post-infectious
immune-mediated radiculopathy that commonly results in neuromuscular
respiratory failure. We present a rare case of GBS secondary to COVID-19
infection. Clinicians should consider COVID-19 as a viral infection that
can trigger immune-mediated pathologies such as GBS. More investigation
is warranted to further understand the pathophysiology relating GBS and
COVID-19.